BackRevance Therapeutics Overview

Revance Therapeutics Total Revenue

Revenue analysis for RVNC.

Quarterly Revenue

$59.88M
↑ 5.47% YoY

As of Sep 2024

Annual Revenue (TTM)

$247.00M
↑ 15.33% YoY

Trailing 12 months ending Sep 2024

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin